BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11815443)

  • 1. Coating stents with antirestenotic drugs: the blunderbuss or the magic bullet?
    Lowe HC; Khachigian LM
    Circulation; 2002 Jan; 105(4):E29. PubMed ID: 11815443
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth.
    Fahmy RG; Khachigian LM
    Nucleic Acids Res; 2004; 32(7):2281-5. PubMed ID: 15107496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic antisense DNA molecules targeting Egr-1 inhibit neointima formation following permanent ligation of rat common carotid arteries.
    Lowe HC; Chesterman CN; Khachigian LM
    Thromb Haemost; 2002 Jan; 87(1):134-40. PubMed ID: 11848443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.
    Khachigian LM
    J Clin Invest; 2000 Nov; 106(10):1189-95. PubMed ID: 11086018
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical use of sirolimus-eluting stents.
    Kirtane AJ; Leon MB
    Cardiovasc Drug Rev; 2007; 25(4):316-32. PubMed ID: 18078432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous deletion of early growth response 1 gene and critical limb ischemia after vascular ligation in mice: evidence for a central role in vascular homeostasis.
    Schalch P; Patejunas G; Retuerto M; Sarateanu S; Milbrandt J; Thakker G; Kim D; Carbray J; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):595-601. PubMed ID: 15457161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
    Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
    Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immediate early genes and vasopressin heteronuclear RNA in the paraventricular and supraoptic nuclei of rats after acute osmotic stimulus.
    Kawasaki M; Yamaguchi K; Saito J; Ozaki Y; Mera T; Hashimoto H; Fujihara H; Okimoto N; Ohnishi H; Nakamura T; Ueta Y
    J Neuroendocrinol; 2005 Apr; 17(4):227-37. PubMed ID: 15842234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
    Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal effects of enriched environment on immediate early gene expression in the rat brain.
    Rönnbäck A; Dahlqvist P; Bergström SA; Olsson T
    Brain Res; 2005 Jun; 1046(1-2):137-44. PubMed ID: 15927552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems.
    Kavanagh CA; Rochev YA; Gallagher WM; Dawson KA; Keenan AK
    Pharmacol Ther; 2004 Apr; 102(1):1-15. PubMed ID: 15056495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic analysis of insulin-like growth factor-I gene transfer in thermally injured rats.
    Dasu MR; Herndon DN; Spies M; Perez-Polo JR
    Wound Repair Regen; 2004; 12(2):217-24. PubMed ID: 15086773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperoxia induces Egr-1 expression through activation of extracellular signal-regulated kinase 1/2 pathway.
    Jones N; Agani FH
    J Cell Physiol; 2003 Aug; 196(2):326-33. PubMed ID: 12811826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of anisomycin on activation of early response genes c-fos, c-jun, Egr-1 in cells transformed by E1A and cHa-ras oncogenes].
    Kukushkin AN; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 2005; 39(1):80-8. PubMed ID: 15773551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
    Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
    Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA cuts its teeth--as an enzyme.
    Finkel E
    Science; 1999 Dec; 286(5449):2441-2. PubMed ID: 10636800
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential gene expression between Zucker Fatty rats and Zucker Diabetic Fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation.
    Garnett KE; Chapman P; Chambers JA; Waddell ID; Boam DS
    J Mol Endocrinol; 2005 Aug; 35(1):13-25. PubMed ID: 16087718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cells.
    Granet C; Miossec P
    Cytokine; 2004 May; 26(4):169-77. PubMed ID: 15149634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.